Low-grade gliomas: An update on pathology and therapy

Lancet Neurology

Volumn 4, Issue 11, 2005, Pages 760-770

  Cavaliere, Robert ^a   Lopes, Maria Beatriz S ^a   Schiff, David ^a  

^a UNIVERSITY OF VIRGINIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

LOMUSTINE; PROCARBAZINE; TEMOZOLOMIDE; VINCRISTINE;

ASTROCYTOMA; BENIGN TUMOR; BONE MARROW TOXICITY; CANCER CHEMOTHERAPY; CANCER EPIDEMIOLOGY; CANCER GRADING; CANCER MORTALITY; CANCER RADIOTHERAPY; CANCER SURGERY; CANCER SURVIVAL; CANCER THERAPY; CARCINOGENESIS; CAUSE OF DEATH; CLINICAL TRIAL; DISEASE SEVERITY; GLIOMA; HUMAN; ILEUS; LOW GRADE GLIOMA; LUNG INJURY; NEUROIMAGING; NEUROPATHOLOGY; NEUROPATHY; NONHUMAN; OLIGODENDROGLIOMA; PRIORITY JOURNAL; PROGNOSIS; REVIEW;

ANIMALS; BRAIN NEOPLASMS; GLIOMA; HUMANS; PROGNOSIS;

EID: 26844513979     PISSN: 14744422     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1474-4422(05)70222-2     Document Type: Review

References (119)

1. P Kleihues, WK Cavenee Pathology and genetics of tumors of the nervous system 2000 IARC Press France
2. A Perry Pathology of low-grade gliomas: an update of emerging concepts Neuro-oncol 5 2003 168 178
3. CBTRUS Statistical report: primary brain tumors in the United States, 1995-1999 2002 Central Brain Tumor Registry of the United States USA
4. H Duffau, L Capelle Preferential brain locations of low-grade gliomas Cancer 100 2004 2622 2626
5. C Leighton, B Fisher, G Bauman Supratentorial low-grade glioma in adults: an analysis of prognostic factors and timing of radiation J Clin Oncol 15 1997 1294
6. J Piepmeier, S Christopher, D Spencer Variations in the natural history and survival of patients with supratentorial low-grade astrocytomas Neurosurgery 38 1996 872 878
7. F Pignatti, M van den Bent, D Curran Prognostic factors for survival in adult patients with cerebral low-grade glioma J Clin Oncol 20 2002 2076 2084
8. M Wrensch, Y Minn, T Chew, M Bondy, MS Berger Epidemiology of primary brain tumors: current concepts and review of the literature Neuro-oncol 4 2002 278 299
9. JW Henson, P Gaviani, RG Gonzalez MRI in treatment of adult gliomas Lancet Oncol 6 2005 167 175
10. E Shaw, R Arusell, B Scheithauer Prospective randomized trial of low- versus high-dose radiation therapy in adults with supratentorial low-grade glioma: initial report of a North Central Cancer Treatment Group/Radiation Therapy Oncology Group/Eastern Cooperative Oncology Group study J Clin Oncol 20 2002 2267 2276
11. FW Kreth, M Faist, R Rossner, B Volk, CB Ostertag Supratentorial World Health Organization grade 2 astrocytomas and oligoastrocytomas: a new pattern of prognostic factors Cancer 79 1997 370 379
12. JD Olson, E Riedel, LM DeAngelis Long-term outcome of low-grade oligodendroglioma and mixed glioma Neurology 54 2000 1442 1448
13. E Karamitopoulou, E Perentes, I Diamantis, T Maraziotis Ki-67 immunoreactivity in human central nervous system tumors: a study with MIB 1 monoclonal antibody on archival material Acta Neuropathol (Berl) 87 1994 47 54
14. TJ Montine, JJ Vandersteenhoven, A Aguzzi Prognostic significance of Ki-67 proliferation index in supratentorial fibrillary astrocytic neoplasms Neurosurgery 34 1994 674 678
15. C Giannini, BW Scheithauer, PC Burger Cellular proliferation in pilocytic and diffuse astrocytomas J Neuropathol Exp Neurol 58 1999 46 53
16. SW Coons, PC Johnson, DK Pearl The prognostic significance of Ki-67 labeling indices for oligodendrogliomas Neurosurgery 41 1997 878 884
17. HG Krouwer, RL Davis, P Silver, M Prados Gemistocytic astrocytomas: a reappraisal J Neurosurg 74 1991 399 406
18. K Watanabe, O Tachibana, Y Yonekawa, P Kleihues, H Ohgaki Role of gemistocytes in astrocytoma progression Lab Invest 76 1997 277 284
19. WK Cavanee, FB Furnari, M Nagane, HJS Huang, EW Newcomb, DD Bigner Diffusely infiltrating astrocytomas P Kleihues WK Cavanee Pathology and genetics of tumours of the central nervous system 2000 IARC Lyon 10 21
20. M Nakamura, T Watanabe, U Klangby p14ARF deletion and methylation in genetic pathways to glioblastomas Brain Pathol 11 2001 159 168
21. PH Wessels, A Twijnstra, AG Kessels Gain of chromosome 7, as detected by in situ hybridization, strongly correlates with shorter survival in astrocytoma grade 2 Genes Chromosomes Cancer 33 2002 279 284
22. PC Burger, AY Minn, JS Smith Losses of chromosomal arms 1p and 19q in the diagnosis of oligodendroglioma: a study of paraffin-embedded sections Mod Pathol 14 2001 842 853
23. JM Kros, CG Van Eden, SZ Stefanko, M Waayer-Van Batenburg, TH van der Kwast Prognostic implications of glial fibrillary acidic protein containing cell types in oligodendrogliomas Cancer 66 1990 1204 1212
24. MJ Herpers, H Budka Glial fibrillary acidic protein (GFAP) in oligodendroglial tumors: gliofibrillary oligodendroglioma and transitional oligoastrocytoma as subtypes of oligodendroglioma Acta Neuropathol (Berl) 64 1984 265 272
25. QR Lu, D Yuk, JA Alberta Sonic hedgehog - regulated oligodendrocyte lineage genes encoding bHLH proteins in the mammalian central nervous system Neuron 25 2000 317 329
26. Q Zhou, S Wang, DJ Anderson Identification of a novel family of oligodendrocyte lineage-specific basic helix-loop-helix transcription factors Neuron 25 2000 331 343
27. QR Lu, JK Park, E Noll Oligodendrocyte lineage genes (OLIG) as molecular markers for human glial brain tumors Proc Natl Acad Sci USA 98 2001 10851 10856
28. K Hoang-Xuan, L Aguirre-Cruz, K Mokhtari, Y Marie, M Sanson OLIG-1 and 2 gene expression and oligodendroglial tumours Neuropathol Appl Neurobiol 28 2002 89 94
29. Y Marie, M Sanson, K Mokhtari OLIG2 as a specific marker of oligodendroglial tumour cells Lancet 358 2001 298 300
30. C Bouvier, C Bartoli, L Aguirre-Cruz Shared oligodendrocyte lineage gene expression in gliomas and oligodendrocyte progenitor cells J Neurosurg 99 2003 344 350
31. KL Ligon, JA Alberta, AT Kho The oligodendroglial lineage marker OLIG2 is universally expressed in diffuse gliomas J Neuropathol Exp Neurol 63 2004 499 509
32. SW Coons, PC Johnson, BW Scheithauer, AJ Yates, DK Pearl Improving diagnostic accuracy and interobserver concordance in the classification and grading of primary gliomas Cancer 79 1997 1381 1393
33. RE McLendon, A Rasheed, R Wiltshire, J Herndon Correlation of 1p-19q-defects in human gliomas with the light microscopic appearance of oligodendroglioma Mod Pathol 17 2004 604 605
34. G Reifenberger, JM Kros, PC Burger Oligodendroglioma P Kleihues WK Cavanee Pathology and genetics of tumours of the central nervous system 2000 IARC Lyon 56 61
35. CE Fuller, A Perry Fluorescence in situ hybridization (FISH) in diagnostic and investigative neuropathology Brain Pathol 12 2002 67 86
36. H Ohgaki, RH Eibl, OD Wiestler, MG Yasargil, EW Newcomb, P Kleihues p53 mutations in nonastrocytic human brain tumors Cancer Res 51 1991 6202 6205
37. G Reifenberger, DN Louis Oligodendroglioma: toward molecular definitions in diagnostic neuro-oncology J Neuropathol Exp Neurol 62 2003 111 126
38. G Reifenberger, JM Kros, PC Burger, DN Louis, VP Collins Oligoastrocytoma P Kleihues WK Cavanee Pathology and genetics of tumours of the central nervous system 2000 IARC Lyon 65 67
39. JA Kraus, J Koopmann, P Kaskel Shared allelic losses on chromosomes 1p and 19q suggest a common origin of oligodendroglioma and oligoastrocytoma J Neuropathol Exp Neurol 54 1995 91 95
40. CE Fuller, RE Schmidt, KA Roth Clinical utility of fluorescence in situ hybridization (FISH) in morphologically ambiguous gliomas with hybrid oligodendroglial/astrocytic features J Neuropathol Exp Neurol 62 2003 1118 1128
41. J Reifenberger, G Reifenberger, L Liu, CD James, W Wechsler, VP Collins Molecular genetic analysis of oligodendroglial tumors shows preferential allelic deletions on 19q and 1p Am J Pathol 145 1994 1175 1190
42. D Maintz, K Fiedler, J Koopmann Molecular genetic evidence for subtypes of oligoastrocytomas J Neuropathol Exp Neurol 56 1997 1098 1104
43. M Begemann, GN Fuller, EC Holland Genetic modeling of glioma formation in mice Brain Pathol 12 2002 117 132
44. WA Weiss, M Israel, C Cobbs Neuropathology of genetically engineered mice: consensus report and recommendations from an international forum Oncogene 21 2002 7453 7463
45. J Weissenberger, JP Steinbach, G Malin, S Spada, T Rulicke, A Aguzzi Development and malignant progression of astrocytomas in GFAP-v-src transgenic mice Oncogene 14 1997 2005 2013
46. H Ding, L Roncari, P Shannon Astrocyte-specific expression of activated p21-ras results in malignant astrocytoma formation in a transgenic mouse model of human gliomas Cancer Res 61 2001 3826 3836
47. C Dai, JC Celestino, Y Okada, DN Louis, GN Fuller, EC Holland PDGF autocrine stimulation dedifferentiates cultured astrocytes and induces oligodendrogliomas and oligoastrocytomas from neural progenitors and astrocytes in vivo Genes Dev 15 2001 1913 1925
48. EC Holland, Y Li, J Celestino Astrocytes give rise to oligodendrogliomas and astrocytomas after gene transfer of polyoma virus middle T antigen in vivo Am J Pathol 157 2000 1031 1037
49. MS Berger, AV Deliganis, J Dobbins, GE Keles The effect of extent of resection on recurrence in patients with low grade cerebral hemisphere gliomas Cancer 74 1994 1784 1791
50. JP Bahary, JG Villemure, S Choi Low-grade pure and mixed cerebral astrocytomas treated in the CT scan era J Neurooncol 27 1996 173 177
51. S Shafqat, ET Hedley-Whyte, JW Henson Age-dependent rate of anaplastic transformation in low-grade astrocytoma Neurology 52 1999 867 869
52. A Franzini, F Leocata, L Cajola, D Servello, A Allegranza, G Broggi Low-grade glial tumors in basal ganglia and thalamus: natural history and biological reappraisal Neurosurgery 35 1994 817 820
53. PE McKeever, L Junck, MS Strawderman Proliferation index is related to patient age in glioblastoma Neurology 56 2001 1216 1218
54. DA Evans, JP Burbach, FW van Leeuwen Somatic mutations in the brain: relationship to aging? Mutat Res 338 1995 173 182
55. PR Schuurman, D Troost, B Verbeeten Jr, DA Bosch 5-year survival and clinical prognostic factors in progressive supratentorial diffuse "low-grade" astrocytoma: a retrospective analysis of 46 cases Acta Neurochir (Wien) 139 1997 2 7
56. F Baumann, M Bjeljac, SS Kollias Combined thalidomide and temozolomide treatment in patients with glioblastoma multiforme J Neurooncol 67 2004 191 200
57. IR Whittle, A Beaumont Seizures in patients with supratentorial oligodendroglial tumours: clinicopathological features and management considerations Acta Neurochir (Wien) 135 1995 19 24
58. K Lote, AE Stenwig, K Skullerud, H Hirschberg Prevalence and prognostic significance of epilepsy in patients with gliomas Eur J Cancer 34 1998 98 102
59. DF Smith, JL Hutton, D Sandemann The prognosis of primary intracerebral tumours presenting with epilepsy: the outcome of medical and surgical management J Neurol Neurosurg Psychiatry 54 1991 915 920
60. JC Bartolomei, S Christopher, K Vives, DD Spencer, JM Piepmeier Low-grade gliomas of chronic epilepsy: a distinct clinical and pathological entity J Neurooncol 34 1997 79 84
61. JM Piepmeier, I Fried, R Makuch Low-grade astrocytomas may arise from different astrocyte lineages Neurosurgery 33 1993 627 632
62. RA Prayson, ML Estes, HH Morris Coexistence of neoplasia and cortical dysplasia in patients presenting with seizures Epilepsia 34 1993 609 615
63. AB Karim, B Maat, R Hatlevoll A randomized trial on dose-response in radiation therapy of low-grade cerebral glioma: European Organization for Research and Treatment of Cancer (EORTC) study 22844 Int J Radiat Onco Biol Phys 36 1996 549
64. PE McKeever, MS Strawderman, B Yamini, AA Mikhail, M Blaivas MIB-1 proliferation index predicts survival among patients with grade II astrocytoma J Neuropathol Exp Neurol 57 1998 931 936
65. G Bauman, K Lote, D Larson Pretreatment factors predict overall survival for patients with low-grade glioma: a recursive partitioning analysis Int J Radiat Oncol Biol Phys 45 1999 923 929
66. FG Barker 2nd, SM Chang, SL Huhn Age and the risk of anaplasia in magnetic resonance-nonenhancing supratentorial cerebral tumors Cancer 80 1997 936 941
67. D Kondziolka, LD Lunsford, AJ Martinez Unreliability of contemporary neurodiagnostic imaging in evaluating suspected adult supratentorial (low-grade) astrocytoma J Neurosurg 79 1993 533 536
68. PJ Kelly, C Daumas-Duport, BW Scheithauer, BA Kall, DB Kispert Stereotactic histologic correlations of computed tomography and magnetic resonance imaging defined abnormalities in patients with glial neoplasms Mayo Clin Proc 62 1987 450 459
69. GE Keles, KR Lamborn, MS Berger Low-grade hemispheric gliomas in adults: a critical review of extent of resection as a factor influencing outcome J Neurosurg 95 2001 735 745
70. A Nicolato, MA Gerosa, P Fina, P Iuzzolino, F Giorgiutti, A Bricolo Prognostic factors in low-grade supratentorial astrocytomas: a uni-multivariate statistical analysis in 76 surgically treated adult patients Surg Neurol 44 1995 208 221
71. GG Grabenbauer, CM Roedel, W Paulus Supratentorial low-grade glioma: results and prognostic factors following postoperative radiotherapy Strahlenther Onkol 176 2000 259 264
72. JR Wood, SB Green, WR Shapiro The prognostic importance of tumor size in malignant gliomas: a computed tomographic scan study by the Brain Tumor Cooperative Group J Clin Oncol 6 1988 338 343
73. Y Shibamoto, Y Kitakabu, M Takahashi Supratentorial low-grade astrocytoma: correlation of computed tomography findings with effect of radiation therapy and prognostic variables Cancer 72 1993 190 195
74. LD Recht, R Lew, TW Smith Suspected low-grade glioma: is deferring treatment safe? Ann Neurol 31 1992 431 436
75. B Jeremic, M Bamberg Radiation therapy for incompletely resected supratentorial low-grade glioma in adults J Neurooncol 55 2001 101 112
76. RA Morantz Radiation therapy in the treatment of cerebral astrocytoma Neurosurgery 20 1987 975 982
77. ML van Veelen, CJ Avezaat, JM Kros, W van Putten, C Vecht Supratentorial low grade astrocytoma: prognostic factors, dedifferentiation, and the issue of early versus late surgery J Neurol Neurosurg Psychiatry 64 1998 581 587
78. JP Knisely, BG Haffty, SR Christopher Early vs delayed radiotherapy in a small cohort of patients with supratentorial low grade glioma J Neurooncol 34 1997 23 29
79. AB Karim, D Afra, P Cornu Randomized trial on the efficacy of radiotherapy for cerebral low-grade glioma in the adult: European Organization for Research and Treatment of Cancer study 22845 with the Medical Research Council study BRO4, an interim analysis Int J Radiat Oncol Biol Phys 52 2002 316 324
80. A Gregor, A Cull Radiotherapy for malignant glioma BMJ 313 1996 1500 1501
81. GM Kiebert, D Curran, NK Aaronson Quality of life after radiation therapy of cerebral low-grade gliomas of the adult: results of a randomised phase III trial on dose response (EORTC trial 22844) Eur J Cancer 34 1998 1902 1909
82. MC Vigliani, C Duyckaerts, JJ Hauw, M Poisson, H Magdelenat, JY Delattre Dementia following treatment of brain tumors with radiotherapy administered alone or in combination with nitrosourea-based chemotherapy: a clinical and pathological study J Neurooncol 41 1999 137 149
83. TE Schultheiss, LE Kun, KK Ang, LC Stephens Radiation response of the central nervous system Int J Radiat Oncol Biol Phys 31 1995 1093 1112
84. CA Meyers, MA Weitzner, AD Valentine, VA Levin Methylphenidate therapy improves cognition, mood, and function of brain tumor patients J Clin Oncol 16 1998 2522 2527
85. T Kaleita, T Cloughesy, J Ford A pilot study of Modafinil for treatment of fatigue and neurobehavioral dysfunctions in adult brain tumor patients Neuro-oncol 6 2004 356
86. SR Rapp, RB D'Agostini, J Lovato, M Naughton, ME Robbins, EG Shaw Improving cognitive functioning in brain irradiated patients: a phase II trial of an acetylcholinesterase inhibitor Neuro-oncol 6 2004 358
87. A Asai, M Matsutani, T Kohno Subacute brain atrophy after radiation therapy for malignant brain tumor Cancer 63 1989 1962 1974
88. MH Swennen, JE Bromberg, TD Witkamp, CH Terhaard, TJ Postma, MJ Taphoorn Delayed radiation toxicity after focal or whole brain radiotherapy for low-grade glioma J Neurooncol 66 2004 333 339
89. BW Corn, DM Yousem, CB Scott White matter changes are correlated significantly with radiation dose: observations from a randomized dose-escalation trial for malignant glioma Cancer 74 1994 2828 2835
90. F Keime-Guibert, M Napolitano, JY Delattre Neurological complications of radiotherapy and chemotherapy J Neurol 245 1998 695 708
91. CL Armstrong, JV Hunter, GE Ledakis Late cognitive and radiographic changes related to radiotherapy: initial prospective findings Neurology 59 2002 40 48
92. O Surma-aho, M Niemela, J Vilkki Adverse long-term effects of brain radiotherapy in adult low-grade glioma patients Neurology 56 2001 1285 1290
93. MC Vigliani, N Sichez, M Poisson, JY Delattre A prospective study of cognitive functions following conventional radiotherapy for supratentorial gliomas in young adults: 4-year results Int J Radiat Oncol Biol Phys 35 1996 527 533
94. M Klein, JJ Heimans, NK Aaronson Effect of radiotherapy and other treatment-related factors on mid-term to long-term cognitive sequelae in low-grade gliomas: a comparative study Lancet 360 2002 1361 1368
95. JC Reijneveld, MM Sitskoorn, M Klein, J Nuyen, MJ Taphoorn Cognitive status and quality of life in patients with suspected versus proven low-grade gliomas Neurology 56 2001 618 623
96. TJ Postma, M Klein, CC Verstappen Radiotherapy-induced cerebral abnormalities in patients with low-grade glioma Neurology 59 2002 121 123
97. PD Brown, JC Buckner, JR O'Fallon Effects of radiotherapy on cognitive function in patients with low-grade glioma measured by the folstein mini-mental state examination J Clin Oncol 21 2003 2519 2524
98. JH Philippon, SH Clemenceau, FH Fauchon, JF Foncin Supratentorial low-grade astrocytomas in adults Neurosurgery 32 1993 554 559
99. EG Shaw, C Daumas-Duport, BW Scheithauer Radiation therapy in the management of low-grade supratentorial astrocytomas J Neurosurg 70 1989 853
100. ER Laws Jr, WF Taylor, MB Clifton, H Okazaki Neurosurgical management of low-grade astrocytoma of the cerebral hemispheres J Neurosurg 61 1984 665 673
101. DM Garcia, KH Fulling, JE Marks The value of radiation therapy in addition to surgery for astrocytomas of the adult cerebrum Cancer 55 1985 919 927
102. KT Shimizu, LM Tran, RJ Mark, MT Selch Management of oligodendrogliomas Radiology 186 1993 569 572
103. JG Cairncross, DR Macdonald Successful chemotherapy for recurrent malignant oligodendroglioma Ann Neurol 23 1988 360 364
104. JG Cairncross, K Ueki, MC Zlatescu Specific genetic predictors of chemotherapeutic response and survival in patients with anaplastic oligodendrogliomas J Natl Cancer Inst 90 1998 1473
105. R Soffietti, R Ruda, GB Bradac, D Schiffer PCV chemotherapy for recurrent oligodendrogliomas and oligoastrocytomas Neurosurgery 43 1998 1066 1073
106. JA Quinn, DA Reardon, AH Friedman Phase II trial of temozolomide in patients with progressive low-grade glioma J Clin Oncol 21 2003 646 651
107. MJ van den Bent, MJ Taphoorn, AA Brandes Phase II study of first-line chemotherapy with temozolomide in recurrent oligodendroglial tumors: the European Organization for Research and Treatment of Cancer Brain Tumor Group Study 26971 J Clin Oncol 21 2003 2525 2528
108. MJ van den Bent, O Chinot, W Boogerd Second-line chemotherapy with temozolomide in recurrent oligodendroglioma after PCV (procarbazine, lomustine and vincristine) chemotherapy: EORTC Brain Tumor Group phase II study 26972 Ann Oncol 14 2003 599 602
109. K Hoang-Xuan, L Capelle, M Kujas Temozolomide as initial treatment for adults with low-grade oligodendrogliomas or oligoastrocytomas and correlation with chromosome 1p deletions J Clin Oncol 22 2004 3133 3138
110. JC Buckner, D Gesme Jr, JR O'Fallon Phase II trial of procarbazine, lomustine, and vincristine as initial therapy for patients with low-grade oligodendroglioma or oligoastrocytoma: efficacy and associations with chromosomal abnormalities J Clin Oncol 21 2003 251 255
111. M Brada, L Viviers, C Abson Phase II study of primary temozolomide chemotherapy in patients with WHO grade II gliomas Ann Oncol 14 2003 1715 1721
112. A Pace, A Vidiri, E Galie Temozolomide chemotherapy for progressive low-grade glioma: clinical benefits and radiological response Ann Oncol 14 2003 1722 1726
113. WP Mason, GS Krol, LM DeAngelis Low-grade oligodendroglioma responds to chemotherapy Neurology 46 1996 203
114. EM Stege, JM Kros, HG de Bruin Successful treatment of low-grade oligodendroglial tumors with a chemotherapy regimen of procarbazine, lomustine, and vincristine Cancer 103 2005 802 809
115. A Chahlavi, A Kanner, D Peereboom, SM Staugaitis, P Elson, G Barnett Impact of chromosome 1p status in response of oligodendroglioma to temozolomide: preliminary results J Neurooncol 61 2003 267 273
116. SJ Danson, MR Middleton Temozolomide: a novel oral alkylating agent Expert Rev Anticancer Ther 1 2001 13 19
117. AW Tolcher, SL Gerson, L Denis Marked inactivation of O6 alkylguanine-DNA alkyltransferase activity with protracted temozolomide schedules Br J Cancer 88 2003 1004 1011
118. H Kurzen, S Schmitt, H Naher, T Mohler Inhibition of angiogenesis by non-toxic doses of temozolomide Anticancer Drugs 14 2003 515 522
119. ME Hegi, AC Diserens, T Gorlia MGMT gene silencing and benefit from temozolomide in glioblastoma N Engl J Med 352 2005 997 1003